Colorcon Announces New Starch Manufacturing Plant In Europe
News Release:
For Immediate Release
Harleysville, Pennsylvania, USA, 19th July 2019, Colorcon Inc. is pleased to announce its investment to build a new starch manufacturing plant close to Amsterdam in The Netherlands. By 2026, this new facility is planned to double the existing manufacturing capacity for Starch 1500®, Pregelatinized Maize Starch, supporting the continued growth of Colorcon’s excipient business across the world.
Strategically located in the heart of Europe and close to the major port of Rotterdam, the site will produce GMP starch products for the pharmaceutical and nutritional markets served by Colorcon in the EMEA region.
Nathan Evans, Operations Project Manager – Netherlands says “the location has been chosen to bring manufacturing closer to our customer base in Europe. The plant will provide a secure second source of supply with the same quality, consistency and equivalency to the product manufactured in our existing facility in Indianapolis, IN, USA. The new facility will enable Colorcon to take advantage of new advances in process control and automation to manufacture a product that has over 40 years of history in use across the pharmaceutical industry.”
Martti Hedman, CEO, Colorcon Inc. explains the significance of Colorcon’s investment “by investing ahead of demand, the facility is also an important step in securing the supply chain for our customers and enhances Colorcon’s Business Continuity Plan as the demand for Starch 1500 continues to grow.”
Jayesh Parmar, General Manager adds, “Colorcon is committed to providing the highest quality products and superior service to meet our customers’ needs around the world. This investment reinforces our dedication to providing continuity of supply and highlights our long-term commitment to the specialty excipient business.”
Company Information
Colorcon is a world leader in the development, supply and technical support of specialty ingredients, formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical, nutritional and animal health industries. Our best-in-class products and technologies are complemented by our extensive application data and value-added services to support all phases of oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a design and development partner of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations. Colorcon has 11 manufacturing facilities, 25 technical service laboratories globally and more than 1400 employees exclusively dedicated to its customer base.
For more information, visit www.colorcon.com
Colorcon Communications Contact:
Katie Scharff
Director - Global Market Communications
katie.scharff@colorcon.com
